Genus Capital Management’s Crocs CROX Stock Holding History

Genus Capital Management’s Portfolio CROX Stock Details CROX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-12,500	Closed	-$1.27M	–	206
2025 Q2	$1.27M	Buy	+12,500	New	+$1.27M	0.16%	124

Other funds holding CROX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WPA

WIT Partners Advisory Singapore $342M AUM 8.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Genus Capital Management's CROX Position: Q3 2025 in Review

Genus Capital Management sold out of Crocs (CROX) in Q3 2025, closing a stake of 12,500 shares — an estimated $1.27M sold.

Genus Capital Management first reported a position in CROX in Q2 2025 and held it in 1 quarter. The position peaked at $1.27M in Q2 2025. 476 funds tracked by Wall St. Rank hold CROX as of Q3 2025.

Genus Capital Management reported no remaining Crocs position as of Q3 2025 after selling out during the quarter.
Genus Capital Management sold 12,500 Crocs shares in Q3 2025, an estimated $1.27M.
Genus Capital Management first reported a position in Crocs in Q2 2025 and held it in 1 quarter.
Genus Capital Management's Crocs position peaked at $1.27M in Q2 2025.
476 funds tracked by Wall St. Rank held Crocs as of Q3 2025.

Based on Genus Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.